Signature of a global and exclusive licence agreement for the exploitation of OphtAI
January 30, 2019
At CES 2019, Evolucare, associated with ADCIS, enters into a global and exclusive license agreement with SATT Ouest Valorisation, a French technology transfer office, and AP-HP Paris hospitals for the exploitation of OphtAI
Innovation : AI at the service of diabetic retinopathy
January 29, 2019
Evolucare Imaging OphtAI (EIO) was designed to significantly facilitate the organization of DR screening and the follow up of patients through time.
The OphDiaT telemedicine network screens 15,000 patients a year for diabetic retinopathy prevention
May 17, 2012
The 35 screening centers and the reading center are equipped with Ophcare, software derived from Evolucare’s Middlec@re collaborative web platform.
Created in 2004 at APHP (Paris hospital network) under the leadership of Prof. Pascale ...
